Enzymatica issues warning and plans fundraising

29 March 2021 - Deborah Wilkes


Enzymatica has warned that sales of its ColdZyme common cold spray may be lower in 2021 than in 2020 due to the impact of the COVID-19 pandemic.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: